Histamine H3 receptor

From WikiMD's WELLNESSPEDIA


== Histamine H3 Receptor ==

The Histamine H3 receptor is a G protein-coupled receptor (GPCR) that is primarily found in the central nervous system (CNS). It is one of the four known histamine receptors, the others being H1, H2, and H4 receptors. The H3 receptor plays a crucial role in modulating the release of various neurotransmitters, including histamine, acetylcholine, dopamine, norepinephrine, and serotonin.

Structure[edit]

The Histamine H3 receptor is a member of the GPCR family, which is characterized by seven transmembrane domains. The receptor is encoded by the HRH3 gene in humans. The structure of the H3 receptor allows it to interact with intracellular G proteins, which in turn modulate various intracellular signaling pathways.

Function[edit]

The primary function of the Histamine H3 receptor is to act as an autoreceptor and heteroreceptor in the CNS. As an autoreceptor, it regulates the synthesis and release of histamine from histaminergic neurons. As a heteroreceptor, it modulates the release of other neurotransmitters, thereby influencing various physiological processes such as sleep, cognition, appetite, and pain perception.

Pharmacology[edit]

The H3 receptor is a target for various pharmacological agents. Agonists of the H3 receptor can inhibit the release of neurotransmitters, while antagonists can enhance their release. This makes the H3 receptor a potential target for the treatment of various neurological and psychiatric disorders, including narcolepsy, attention deficit hyperactivity disorder (ADHD), and schizophrenia.

Clinical Significance[edit]

Dysfunction of the Histamine H3 receptor has been implicated in several medical conditions. For instance, altered H3 receptor activity has been associated with sleep disorders, cognitive impairments, and neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Research is ongoing to develop H3 receptor modulators as therapeutic agents for these conditions.

See Also[edit]

References[edit]


External Links[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.